{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:02:11Z","timestamp":1789740131707,"version":"4.0.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shandong Provincial Natural Science Foundation","award":["ZR2023MH329"],"award-info":[{"award-number":["ZR2023MH329"]}]},{"name":"Project of Shandong Province Higher Educational Youth Innovation Science and Technology Program","award":["2023KJ263"],"award-info":[{"award-number":["2023KJ263"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12766-y","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:05:15Z","timestamp":1789736715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The CCT6A paradigm: biomarker potential and therapeutic challenges in oncology and beyond"],"prefix":"10.1007","volume":"53","author":[{"given":"Rui-Hang","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Peng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Wen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Nan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4127-904X","authenticated-orcid":false,"given":"Si-Yuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"issue":"Pt 1","key":"12766_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semcancer.2021.05.029","volume":"86","author":"AJL Macario","year":"2022","unstructured":"Macario AJL, Conway de Macario E (2022) Chaperonins in cancer: expression, function, and migration in extracellular vesicles. Semin Cancer Biol 86(Pt 1):26\u201335. https:\/\/doi.org\/10.1016\/j.semcancer.2021.05.029","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"12766_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-04915-x","volume":"6","author":"C Liu","year":"2023","unstructured":"Liu C, Jin M, Wang S, Han W, Zhao Q, Wang Y, Xu C, Diao L, Yin Y, Peng C, Bao L, Wang Y, Cong Y (2023) Pathway and mechanism of tubulin folding mediated by TRiC\/CCT along its ATPase cycle revealed using cryo-EM. Commun Biol 6(1):531. https:\/\/doi.org\/10.1038\/s42003-023-04915-x","journal-title":"Commun Biol"},{"key":"12766_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.sbi.2019.03.002","volume":"55","author":"D Gestaut","year":"2019","unstructured":"Gestaut D, Limatola A, Joachimiak L, Frydman J (2019) The ATP-powered gymnastics of TRiC\/CCT: an asymmetric protein folding machine with a symmetric origin story. Curr Opin Struct Biol 55:50\u201358. https:\/\/doi.org\/10.1016\/j.sbi.2019.03.002","journal-title":"Curr Opin Struct Biol"},{"key":"12766_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2025.102999","volume":"91","author":"PS Shen","year":"2025","unstructured":"Shen PS, Willardson BM (2025) Protein folding by the CCT\/TRiC chaperone complex. Curr Opin Struct Biol 91:102999. https:\/\/doi.org\/10.1016\/j.sbi.2025.102999","journal-title":"Curr Opin Struct Biol"},{"issue":"3","key":"12766_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mocell.2024.100012","volume":"47","author":"H Kim","year":"2024","unstructured":"Kim H, Park J, Roh SH (2024) The structural basis of eukaryotic chaperonin TRiC\/CCT: action and folding. Mol Cells 47(3):100012. https:\/\/doi.org\/10.1016\/j.mocell.2024.100012","journal-title":"Mol Cells"},{"key":"12766_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202506674","author":"H Sun","year":"2025","unstructured":"Sun H, Zhang T, Zhang X, Liu Y, Wang X, Wang X, Tan C, Ni S, Weng W, Zhang M, Wang L, Huang D, Wang X, Wang W, Sheng W, Xu MD (2025) Exosomal CCT6A secreted by cancer-associated fibroblasts interacts with beta-catenin to enhance chemoresistance and tumorigenesis in gastric cancer. Adv sci. https:\/\/doi.org\/10.1002\/advs.202506674","journal-title":"Adv sci"},{"issue":"16","key":"12766_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411285","volume":"12","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Tan X, Wang L, Ji D, Zhang C, Peng W, Zhu R, Wang X, Zhou J, Feng Y, Sun Y (2025) TRIM38 suppresses the progression of colorectal cancer via enhancing CCT6A ubiquitination to inhibit the MYC pathway. Adv Sci 12(16):e2411285. https:\/\/doi.org\/10.1002\/advs.202411285","journal-title":"Adv Sci"},{"key":"12766_CR8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2018127118","author":"JJ Knowlton","year":"2021","unstructured":"Knowlton JJ, Gestaut D, Ma B, Taylor G, Seven AB, Leitner A, Wilson GJ, Shanker S, Yates NA, Prasad BVV, Aebersold R, Chiu W, Frydman J, Dermody TS (2021) Structural and functional dissection of reovirus capsid folding and assembly by the prefoldin-TRiC\/CCT chaperone network. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2018127118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12766_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.01245","volume":"10","author":"M Hu","year":"2019","unstructured":"Hu M, Fu X, Si Z, Li C, Sun J, Du X, Zhang H (2019) Identification of differently expressed genes associated with prognosis and growth in colon adenocarcinoma based on integrated bioinformatics analysis. Front Genet 10:1245. https:\/\/doi.org\/10.3389\/fgene.2019.01245","journal-title":"Front Genet"},{"issue":"1","key":"12766_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0890-1","volume":"17","author":"YS Ma","year":"2018","unstructured":"Ma YS, Huang T, Zhong XM, Zhang HW, Cong XL, Xu H, Lu GX, Yu F, Xue SB, Lv ZW, Fu D (2018) Proteogenomic characterization and comprehensive integrative genomic analysis of human colorectal cancer liver metastasis. Mol Cancer 17(1):139. https:\/\/doi.org\/10.1186\/s12943-018-0890-1","journal-title":"Mol Cancer"},{"key":"12766_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-024-00806-3","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zheng T, Qin C, Zhang X, Lin H, Huang X, Liu Q, Chang S, Zhang L, Guo J, Zhang Y, Bian C, Liu H (2024) CCT6A promotes cell proliferation in colon cancer by targeting BIRC5 associated with p53 status. Cancer Gene Ther. https:\/\/doi.org\/10.1038\/s41417-024-00806-3","journal-title":"Cancer Gene Ther"},{"key":"12766_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.629856","volume":"12","author":"H Sun","year":"2021","unstructured":"Sun H, Wang Y, Jing HY, Yang XY, Shi XX, Zhang JH, Yu YX, Gao L, Wang XY, Li WH, Yu L (2021) Chaperonin-containing TCP1 subunit 6A is a prognostic potential biomarker that correlates with the presence of immune infiltrates in colorectal cancer. Front Genet 12:629856. https:\/\/doi.org\/10.3389\/fgene.2021.629856","journal-title":"Front Genet"},{"key":"12766_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.691142","volume":"12","author":"J Hu","year":"2021","unstructured":"Hu J, Han C, Zhong J, Liu H, Liu R, Luo W, Chen P, Ling F (2021) Dynamic network biomarker of pre-exhausted CD8(+) T cells contributed to T cell exhaustion in colorectal cancer. Front Immunol 12:691142. https:\/\/doi.org\/10.3389\/fimmu.2021.691142","journal-title":"Front Immunol"},{"issue":"18","key":"12766_CR14","doi-asserted-by":"publisher","first-page":"5897","DOI":"10.7150\/jca.98901","volume":"15","author":"J Ma","year":"2024","unstructured":"Ma J, Wei Q, Zhang L, Sun F, Li W, Du R, Liu M, Yan S, Wang C (2024) CCT6A functions as promising diagnostic biomarker and promotes cell proliferation in colorectal cancer. J Cancer 15(18):5897\u20135909. https:\/\/doi.org\/10.7150\/jca.98901","journal-title":"J Cancer"},{"key":"12766_CR15","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i18.105729","author":"JX Ma","year":"2025","unstructured":"Ma JX, Li XJ, Li YL, Liu MC, Du RH, Cheng Y, Li LJ, Ai ZY, Jiang JT, Yan SY (2025) Chaperonin-containing tailless complex polypeptide 1 subunit 6A negatively regulates autophagy and protects colorectal cancer cells from cisplatin-induced cytotoxicity. World J Gastroenterol WJG. https:\/\/doi.org\/10.3748\/wjg.v31.i18.105729","journal-title":"World J Gastroenterol WJG"},{"key":"12766_CR16","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2022.12690","author":"X Yang","year":"2022","unstructured":"Yang X, Tong Y, Ye W, Chen L (2022) HOXB2 increases the proliferation and invasiveness of colon cancer cells through the upregulation of CCT6A. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2022.12690","journal-title":"Mol Med Rep"},{"issue":"1","key":"12766_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.21037\/jgo-22-97","volume":"13","author":"X Zhong","year":"2022","unstructured":"Zhong X, Ni J, Jia Z, Yan H, Zhang Y, Liu Y (2022) CBX3 is associated with metastasis and glutathione\/glycosphingolipid metabolism in colon adenocarcinoma. J Gastrointest Oncol 13(1):246\u2013255. https:\/\/doi.org\/10.21037\/jgo-22-97","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"12766_CR18","doi-asserted-by":"publisher","first-page":"e610","DOI":"10.1097\/CAD.0000000000001198","volume":"33","author":"X Peng","year":"2022","unstructured":"Peng X, Chen G, Lv B, Lv J (2022) MicroRNA-148a\/152 cluster restrains tumor stem cell phenotype of colon cancer via modulating CCT6A. Anticancer Drugs 33(1):e610\u2013e621. https:\/\/doi.org\/10.1097\/CAD.0000000000001198","journal-title":"Anticancer Drugs"},{"key":"12766_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/mc.70070","author":"F Chen","year":"2026","unstructured":"Chen F, Liu C, Jiang R, Wang H (2026) CCT6A promotes colon cancer cell proliferation, migration, and invasion by modulating fatty acid metabolism and activating the TGF-beta1\/Smad signaling pathway. Molecul Carcinogenesis. https:\/\/doi.org\/10.1002\/mc.70070","journal-title":"Molecul Carcinogenesis"},{"issue":"3","key":"12766_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101796","volume":"46","author":"Y Cai","year":"2022","unstructured":"Cai Y, Wu D, Zhan L (2022) CCT6A expression in hepatocellular carcinoma and its correlation with clinical characteristics, liver function indexes, tumor markers and prognosis. Clin Res Hepatol Gastroenterol 46(3):101796. https:\/\/doi.org\/10.1016\/j.clinre.2021.101796","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"12766_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.668871","volume":"12","author":"W Li","year":"2021","unstructured":"Li W, Liu J, Zhao H (2021) Prognostic power of a chaperonin containing TCP-1 subunit genes panel for hepatocellular carcinoma. Front Genet 12:668871. https:\/\/doi.org\/10.3389\/fgene.2021.668871","journal-title":"Front Genet"},{"issue":"6","key":"12766_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s10142-024-01497-7","volume":"24","author":"H Cui","year":"2024","unstructured":"Cui H, Jiang L, Zhou Y, Zhou Y, Li F, Zhang Z (2024) Serine related gene CCT6A promotes metastasis of hepatocellular carcinoma via interacting with RPS3. Funct Integr Genomics 24(6):225. https:\/\/doi.org\/10.1007\/s10142-024-01497-7","journal-title":"Funct Integr Genomics"},{"issue":"4","key":"12766_CR23","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s12079-023-00772-9","volume":"17","author":"W Zhao","year":"2023","unstructured":"Zhao W, Xi L, Yu G, Wang G, Chang C (2023) High expression of GPR50 promotes the proliferation, migration and autophagy of hepatocellular carcinoma cells in vitro. J Cell Commun Signal 17(4):1435\u20131447. https:\/\/doi.org\/10.1007\/s12079-023-00772-9","journal-title":"J Cell Commun Signal"},{"key":"12766_CR24","doi-asserted-by":"publisher","first-page":"10427","DOI":"10.2147\/OTT.S229231","volume":"12","author":"G Zeng","year":"2019","unstructured":"Zeng G, Wang J, Huang Y, Lian Y, Chen D, Wei H, Lin C, Huang Y (2019) Overexpressing CCT6A contributes to cancer cell growth by affecting the G1-to-S phase transition and predicts a negative prognosis in hepatocellular carcinoma. Onco Targets Ther 12:10427\u201310439. https:\/\/doi.org\/10.2147\/OTT.S229231","journal-title":"Onco Targets Ther"},{"issue":"9","key":"12766_CR25","first-page":"3329","volume":"12","author":"L Yao","year":"2019","unstructured":"Yao L, Zou X, Liu L (2019) The TCP1 ring complex is associated with malignancy and poor prognosis in hepatocellular carcinoma. Int J Clinical Experimental Pathol 12(9):3329\u20133343","journal-title":"Int J Clinical Experimental Pathol"},{"issue":"9","key":"12766_CR26","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/jat.4463","volume":"43","author":"JF Foley","year":"2023","unstructured":"Foley JF, Elgart B, Phadke D, Mav D, Tripodi I, Clausen N, Weick M, Gladwell W, Gerrish K, Shah R, Merrick BA (2023) Whole exome and transcript profiling of liver following aflatoxin B1 exposure in rats. J Appl Toxicol 43(9):1293\u20131305. https:\/\/doi.org\/10.1002\/jat.4463","journal-title":"J Appl Toxicol"},{"issue":"9","key":"12766_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0330722","volume":"20","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Fu C, Liu S, Leng Y, Duan L, Wang N, Zhang L, Qiao H (2025) Construction and validation of a prognostic model based on mitochondria-associated endoplasmic reticulum membranes gene signature in LUAD patients. PLoS ONE 20(9):e0330722. https:\/\/doi.org\/10.1371\/journal.pone.0330722","journal-title":"PLoS ONE"},{"issue":"7","key":"12766_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06008-3","volume":"14","author":"T Yu","year":"2023","unstructured":"Yu T, Zhang Q, Yu SK, Nie FQ, Zhang ML, Wang Q, Lu KH (2023) THOC3 interacts with YBX1 to promote lung squamous cell carcinoma progression through PFKFB4 mRNA modification. Cell Death Dis 14(7):475. https:\/\/doi.org\/10.1038\/s41419-023-06008-3","journal-title":"Cell Death Dis"},{"issue":"1","key":"12766_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05284-7","volume":"22","author":"SK Yu","year":"2024","unstructured":"Yu SK, Yu T, Wang YM, Sun A, Liu J, Lu KH (2024) CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1\/HK2 axis. J Transl Med 22(1):460. https:\/\/doi.org\/10.1186\/s12967-024-05284-7","journal-title":"J Transl Med"},{"issue":"5","key":"12766_CR30","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1172\/JCI90439","volume":"127","author":"Z Ying","year":"2017","unstructured":"Ying Z, Tian H, Li Y, Lian R, Li W, Wu S, Zhang HZ, Wu J, Liu L, Song J, Guan H, Cai J, Zhu X, Li J, Li M (2017) CCT6A suppresses SMAD2 and promotes prometastatic TGF-beta signaling. J Clinical Investigation 127(5):1725\u20131740. https:\/\/doi.org\/10.1172\/JCI90439","journal-title":"J Clinical Investigation"},{"key":"12766_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1560199","author":"H Wang","year":"2022","unstructured":"Wang H, Wang X, Xu L, Lin Y, Zhang J (2022) CCT6A and CHCHD2 are coamplified with EGFR and associated with the unfavorable clinical outcomes of lung adenocarcinoma. Dis Markers. https:\/\/doi.org\/10.1155\/2022\/1560199","journal-title":"Dis Markers"},{"key":"12766_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.844691","volume":"12","author":"W Tang","year":"2022","unstructured":"Tang W, Lu Q, Zhu J, Zheng X, Fang N, Ji S, Lu F (2022) Identification of a prognostic signature composed of GPI, IL22RA1, CCT6A and SPOCK1 for lung adenocarcinoma based on bioinformatic analysis of lncRNA-mediated ceRNA network and sample validation. Front Oncol 12:844691. https:\/\/doi.org\/10.3389\/fonc.2022.844691","journal-title":"Front Oncol"},{"issue":"13","key":"12766_CR33","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.2174\/1386207325666220324092231","volume":"25","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wu Q, Li J, Jia W, Zhai X, Yu J, Zhu H (2022) Comprehensive analysis and validation of competing endogenous RNA network and tumor-infiltrating immune cells in lung adenocarcinoma. Comb Chem High Throughput Screen 25(13):2240\u20132254. https:\/\/doi.org\/10.2174\/1386207325666220324092231","journal-title":"Comb Chem High Throughput Screen"},{"key":"12766_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-62707-9","author":"T Li","year":"2026","unstructured":"Li T, Wu D, Yang A, Li J, Zhou Z, Zheng Q (2026) A Rho GTPase-related gene signature predicts prognosis and reveals an immunosuppressive microenvironment in lung adenocarcinoma: an integrated analysis of bulk and single-cell RNA sequencing data. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-026-62707-9","journal-title":"Sci Rep"},{"key":"12766_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2026.109054","author":"H Liu","year":"2026","unstructured":"Liu H, Hu Y, Wang L, Li C, Li D, Meng L, Zheng G, Ren J, Shang L, Bao Y (2026) A palmitoylation-related prognostic risk scoring model and tumor microenvironment characterization in lung adenocarcinoma, using single-cell RNA sequencing data. Computational Biol Chemistry. https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.109054","journal-title":"Computational Biol Chemistry"},{"key":"12766_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-024-03752-6","author":"X Cao","year":"2025","unstructured":"Cao X, Xi J, Wang C, Yu W, Wang Y, Zhu J, Xu K, Pan D, Chen C, Han Z (2025) Integrated analysis of single-cell and bulk RNA-sequencing identifies a metastasis-related gene signature for predicting prognosis in lung adenocarcinoma. Clinical Translational Oncol Official Publication Federation Spanish Oncol Societies National Cancer Institute Mexico. https:\/\/doi.org\/10.1007\/s12094-024-03752-6","journal-title":"Clinical Translational Oncol Official Publication Federation Spanish Oncol Societies National Cancer Institute Mexico"},{"issue":"10","key":"12766_CR37","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s00210-023-02460-2","volume":"396","author":"M Wang","year":"2023","unstructured":"Wang M, Zhao F, Li Z, Li X, Dong L (2023) Tectoridin and PLK1 inhibitor synergistically promote the apoptosis of lung adenocarcinoma cells: bioinformatic analysis of TCGA and TCMSP. Naunyn Schmiedebergs Arch Pharmacol 396(10):2417\u20132426. https:\/\/doi.org\/10.1007\/s00210-023-02460-2","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"12766_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s10142-024-01499-5","author":"H Li","year":"2024","unstructured":"Li H, Yang L, Yang Q, Liang Z, Su W, Yu L (2024) Integration of osimertinib-targeted EGFR gene-associated differential gene expression in constructing a prognostic model for lung adenocarcinoma. Functional Integrative Genomics. https:\/\/doi.org\/10.1007\/s10142-024-01499-5","journal-title":"Functional Integrative Genomics"},{"key":"12766_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105394","author":"Z Zheng","year":"2022","unstructured":"Zheng Z, Li Y, Lu X, Zhang J, Liu Q, Zhou D, Deng X, Qiu Y, Chen Q, Zheng H, Dai J (2022) A novel mTOR-associated gene signature for predicting prognosis and evaluating tumor immune microenvironment in lung adenocarcinoma. Computers Biol Med. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.105394","journal-title":"Computers Biol Med"},{"key":"12766_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85620-z","author":"W Yang","year":"2025","unstructured":"Yang W, Gu M, Zhang Y, Zhang Y, Liu T, Wu D, Deng J, Liu M, Zhang Y (2025) A method for the identification of lactate metabolism-related prognostic biomarkers and its validations in non-small cell lung cancer. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-025-85620-z","journal-title":"Sci Rep"},{"key":"12766_CR41","doi-asserted-by":"publisher","DOI":"10.3779\/j.issn.1009-3419.2025.102.04","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Zhao W, Hu Z, Ding C, Huang H, Liang G, Liu H, Chen J (2025) Construction and Validation of A Prognostic Model for Lung Adenocarcinoma Based on Ferroptosis-related Genes. Zhongguo Fei Ai Za Zhi = Chinese J lung Cancer. https:\/\/doi.org\/10.3779\/j.issn.1009-3419.2025.102.04","journal-title":"Zhongguo Fei Ai Za Zhi = Chinese J lung Cancer"},{"issue":"4","key":"12766_CR42","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jtho.2016.12.025","volume":"12","author":"M Zhu","year":"2017","unstructured":"Zhu M, Geng L, Shen W, Wang Y, Liu J, Cheng Y, Wang C, Dai J, Jin G, Hu Z, Ma H, Shen H (2017) Exome-wide association study identifies low-frequency coding variants in 2p23.2 and 7p11.2 associated with survival of non-small cell lung cancer patients. J Thoracic Oncol Official Publication Int Association Study Lung Cancer 12(4):644\u2013656. https:\/\/doi.org\/10.1016\/j.jtho.2016.12.025","journal-title":"J Thoracic Oncol Official Publication Int Association Study Lung Cancer"},{"key":"12766_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00893-x","author":"K Cao","year":"2025","unstructured":"Cao K, Wei S, Ma T, Yang X, Wang Y, He X, Lu M, Bai Y, Qi C, Zhang L, Li L, Meng H, Ma J, Zhu J (2025) Integrating bulk, single-cell, and spatial transcriptomics to identify and functionally validate novel targets to enhance immunotherapy in NSCLC. NPJ Precision Oncol. https:\/\/doi.org\/10.1038\/s41698-025-00893-x","journal-title":"NPJ Precision Oncol"},{"key":"12766_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.637887","volume":"12","author":"WX Xu","year":"2021","unstructured":"Xu WX, Song W, Jiang MP, Yang SJ, Zhang J, Wang DD, Tang JH (2021) Systematic characterization of expression profiles and prognostic values of the eight subunits of the chaperonin TRiC in breast cancer. Front Genet 12:637887. https:\/\/doi.org\/10.3389\/fgene.2021.637887","journal-title":"Front Genet"},{"key":"12766_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cells12081182","author":"R Vishnubalaji","year":"2023","unstructured":"Vishnubalaji R, Alajez NM (2023) Single-cell transcriptome analysis revealed heterogeneity and identified novel therapeutic targets for breast cancer subtypes. Cells. https:\/\/doi.org\/10.3390\/cells12081182","journal-title":"Cells"},{"key":"12766_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43556-1","author":"M Klimczak","year":"2019","unstructured":"Klimczak M, Biecek P, Zylicz A, Zylicz M (2019) Heat shock proteins create a signature to predict the clinical outcome in breast cancer. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-019-43556-1","journal-title":"Sci Rep"},{"key":"12766_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.155938","author":"MG Bal Albayrak","year":"2025","unstructured":"Bal Albayrak MG, Simsek T, Akpinar G, Kasap M, Canturk NZ (2025) Proteomic insights into lymph node metastasis in breast cancer subtypes: Key biomarkers and pathways. Pathol Research Practice. https:\/\/doi.org\/10.1016\/j.prp.2025.155938","journal-title":"Pathol Research Practice"},{"key":"12766_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70097","author":"M Yang","year":"2024","unstructured":"Yang M, Cao J, Liu T, Li B, Wang J, Pan S, Guo D, Tao Z, Hu X (2024) Chaperonin-containing TCP1 subunit 6A inhibition via TRIM21-mediated K48-linked ubiquitination suppresses triple-negative breast cancer progression through the AKT signalling pathway. Clinical Translational Med. https:\/\/doi.org\/10.1002\/ctm2.70097","journal-title":"Clinical Translational Med"},{"issue":"5","key":"12766_CR49","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.3892\/mmr.2019.10100","volume":"19","author":"K Huang","year":"2019","unstructured":"Huang K, Zeng Y, Xie Y, Huang L, Wu Y (2019) Bioinformatics analysis of the prognostic value of CCT6A and associated signalling pathways in breast cancer. Mol Med Rep 19(5):4344\u20134352. https:\/\/doi.org\/10.3892\/mmr.2019.10100","journal-title":"Mol Med Rep"},{"issue":"1","key":"12766_CR50","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2287122","volume":"25","author":"Y Chen","year":"2024","unstructured":"Chen Y, Chen Y, Liu W (2024) Chaperonin containing TCP1 subunit 6A may activate Notch and Wnt pathways to facilitate the malignant behaviors and cancer stemness in oral squamous cell carcinoma. Cancer Biol Ther 25(1):2287122. https:\/\/doi.org\/10.1080\/15384047.2023.2287122","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"12766_CR51","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1007\/s00405-021-06955-7","volume":"279","author":"Y Shi","year":"2022","unstructured":"Shi Y, Liang Y, Wang W, Zhang G (2022) SEC61G identified as a prognostic biomarker of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 279(4):2039\u20132048. https:\/\/doi.org\/10.1007\/s00405-021-06955-7","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"12766_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1031210","volume":"13","author":"B Liu","year":"2022","unstructured":"Liu B, Hu Y, Wan L, Wang L, Cheng L, Sun H, Liu Y, Wu D, Zhu J, Hong X, Li Y, Zhou C (2022) Proteomics analysis of cancer tissues identifies IGF2R as a potential therapeutic target in laryngeal carcinoma. Front Endocrinol 13:1031210. https:\/\/doi.org\/10.3389\/fendo.2022.1031210","journal-title":"Front Endocrinol"},{"issue":"1","key":"12766_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0846-5","volume":"17","author":"F Qadir","year":"2018","unstructured":"Qadir F, Aziz MA, Sari CP, Ma H, Dai H, Wang X, Raithatha D, Da Silva LGL, Hussain M, Poorkasreiy SP, Hutchison IL, Waseem A, Teh MT (2018) Transcriptome reprogramming by cancer exosomes: identification of novel molecular targets in matrix and immune modulation. Mol Cancer 17(1):97. https:\/\/doi.org\/10.1186\/s12943-018-0846-5","journal-title":"Mol Cancer"},{"issue":"9","key":"12766_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24609","volume":"36","author":"W Peng","year":"2022","unstructured":"Peng W, Li W, Zhang X, Cen W, Liu Y (2022) The intercorrelation among CCT6A, CDC20, CCNB1, and PLK1 expressions and their clinical value in papillary thyroid carcinoma prognostication. J Clin Lab Anal 36(9):e24609. https:\/\/doi.org\/10.1002\/jcla.24609","journal-title":"J Clin Lab Anal"},{"key":"12766_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135086","volume":"732","author":"B Li","year":"2020","unstructured":"Li B, Lu X, Ma C, Sun S, Shu X, Wang Z, Sun W (2020) Long non-coding RNA NEAT1 promotes human glioma tumor progression via miR-152-3p\/CCT6A pathway. Neurosci Lett 732:135086. https:\/\/doi.org\/10.1016\/j.neulet.2020.135086","journal-title":"Neurosci Lett"},{"issue":"1-2","key":"12766_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201800157","volume":"19","author":"S Hallal","year":"2019","unstructured":"Hallal S, Russell BP, Wei H, Lee MYT, Toon CW, Sy J, Shivalingam B, Buckland ME, Kaufman KL (2019) Extracellular vesicles from neurosurgical aspirates identifies chaperonin containing TCP1 subunit 6A as a potential glioblastoma biomarker with prognostic significance. Proteomics 19(1\u20132):e1800157. https:\/\/doi.org\/10.1002\/pmic.201800157","journal-title":"Proteomics"},{"key":"12766_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23917","author":"Y Hu","year":"2021","unstructured":"Hu Y, Fu P, Zhao H, Zhang F, Jiang X, Zhao W, Lv P (2021) Chaperonin-containing tailless complex polypeptide 1 subunit 6A correlates with increased World Health Organization grade, less isocitrate dehydrogenase mutation, and deteriorative survival of astrocytoma patients. J Clinical Laboratory Analysis. https:\/\/doi.org\/10.1002\/jcla.23917","journal-title":"J Clinical Laboratory Analysis"},{"key":"12766_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32650","author":"A Di Meo","year":"2020","unstructured":"Di Meo A, Batruch I, Brown MD, Yang C, Finelli A, Jewett MA, Diamandis EP, Yousef GM (2020) Searching for prognostic biomarkers for small renal masses in the urinary proteome. Int J cancer J Du Cancer. https:\/\/doi.org\/10.1002\/ijc.32650","journal-title":"Int J cancer J Du Cancer"},{"key":"12766_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2022.101913","author":"T He","year":"2022","unstructured":"He T, Yu D, Wang Z, Guo C, Chang Y, Wang D (2022) Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: A long-term follow-up study. Clinics Research Hepatol Gastroenterol. https:\/\/doi.org\/10.1016\/j.clinre.2022.101913","journal-title":"Clinics Research Hepatol Gastroenterol"},{"issue":"16","key":"12766_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14163891","volume":"14","author":"X Zhou","year":"2022","unstructured":"Zhou X, Zhang B, Zheng G, Zhang Z, Wu J, Du K, Zhang J (2022) Novel necroptosis-related gene signature for predicting early diagnosis and prognosis and immunotherapy of gastric cancer. Cancers Basel 14(16):36010886. https:\/\/doi.org\/10.3390\/cancers14163891","journal-title":"Cancers Basel"},{"key":"12766_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-025-11132-0","author":"KL Wang","year":"2025","unstructured":"Wang KL, Xi XX, Zheng JH (2025) A novel telomere maintenance gene-related model for prognosis prediction in gastric cancer. Biochem Genet. https:\/\/doi.org\/10.1007\/s10528-025-11132-0","journal-title":"Biochem Genet"},{"key":"12766_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.617289","volume":"11","author":"W Zhou","year":"2021","unstructured":"Zhou W, Li J, Lu X, Liu F, An T, Xiao X, Kuo ZC, Wu W, He Y (2021) Derivation and validation of a prognostic model for cancer dependency genes based on CRISPR-Cas9 in gastric adenocarcinoma. Front Oncol 11:617289. https:\/\/doi.org\/10.3389\/fonc.2021.617289","journal-title":"Front Oncol"},{"key":"12766_CR63","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-023-03357-y","author":"X Xia","year":"2023","unstructured":"Xia X, Zhao S, Chen W, Xu C, Zhao D (2023) CCT6A promotes esophageal squamous cell carcinoma cell proliferation, invasion and epithelial-mesenchymal transition by activating TGF-beta\/Smad\/c-Myc pathway. Irish J Medical Sci. https:\/\/doi.org\/10.1007\/s11845-023-03357-y","journal-title":"Irish J Medical Sci"},{"key":"12766_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1755582","volume":"16","author":"R Jie","year":"2026","unstructured":"Jie R, Liu Y, Wang T, Wusiman S, Ren H, Tuoheniyazi W, Liu L (2026) Prognostic biomarkers related to PANoptosis in esophageal cancer and their immune microenvironment: multi-omics analysis and therapeutic significance. Front Oncol 16:1755582. https:\/\/doi.org\/10.3389\/fonc.2026.1755582","journal-title":"Front Oncol"},{"issue":"1","key":"12766_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07720-y","volume":"16","author":"T Ma","year":"2025","unstructured":"Ma T, Guo WW, Zhang M, He W, Dongzhi C, Gongye X, Xia P, Chai Y, Chen Z, Zhu Y, Qu C, Liu J, Yang Z, Ma W, Tian M, Yuan Y (2025) Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma. Cell Death Dis 16(1):382. https:\/\/doi.org\/10.1038\/s41419-025-07720-y","journal-title":"Cell Death Dis"},{"issue":"3A","key":"12766_CR66","first-page":"2137","volume":"26","author":"N Tanic","year":"2006","unstructured":"Tanic N, Brkic G, Dimitrijevic B, Dedovic-Tanic N, Gefen N, Benharroch D, Gopas J (2006) Identification of differentially expressed mRNA transcripts in drug-resistant versus parental human melanoma cell lines. Anticancer Res 26(3A):2137\u20132142","journal-title":"Anticancer Res"},{"key":"12766_CR67","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2015.1070981","author":"S Hofflin","year":"2015","unstructured":"Hofflin S, Prommersberger S, Uslu U, Schuler G, Schmidt CW, Lennerz V, Dorrie J, Schaft N (2015) Generation of CD8(+) T cells expressing two additional T-cell receptors (TETARs) for personalised melanoma therapy. Cancer Biol Therapy. https:\/\/doi.org\/10.1080\/15384047.2015.1070981","journal-title":"Cancer Biol Therapy"},{"key":"12766_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0279851","author":"W Zeng","year":"2022","unstructured":"Zeng W, Wu M, Cheng Y, Liu L, Han Y, Xie Q, Li J, Wei L, Fang Y, Chen Y, Peng J, Shen A (2022) CCT6A knockdown suppresses osteosarcoma cell growth and Akt pathway activation in vitro. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0279851","journal-title":"PLoS ONE"},{"issue":"12","key":"12766_CR69","doi-asserted-by":"publisher","first-page":"8365","DOI":"10.21037\/tcr-2025-1366","volume":"14","author":"X Huang","year":"2025","unstructured":"Huang X, Xiong L, Zeng J, Li S, Cai Y, Zou Z, Yang M, Li H, Liu Y, He M (2025) Molecular characterization and prognostic modeling of liquid-liquid phase separation-related genes in osteosarcoma based on single-cell sequencing and weighted gene co-expression network analysis. Transl Cancer Res 14(12):8365\u20138384. https:\/\/doi.org\/10.21037\/tcr-2025-1366","journal-title":"Transl Cancer Res"},{"issue":"4","key":"12766_CR70","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024484","volume":"100","author":"J Jiang","year":"2021","unstructured":"Jiang J, Liu C, Xu G, Liang T, Yu C, Liao S, Zhang Z, Lu Z, Wang Z, Chen J, Chen T, Li H, Zhan X (2021) CCT6A, a novel prognostic biomarker for Ewing sarcoma. Medicine 100(4):e24484. https:\/\/doi.org\/10.1097\/MD.0000000000024484","journal-title":"Medicine"},{"issue":"3","key":"12766_CR71","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.31557\/APJCP.2025.26.3.1079","volume":"26","author":"EA Saad","year":"2025","unstructured":"Saad EA, Abd Allah MYY, Abd-El-Hameed SAE, Abdel-Aziz A, Khaled Z (2025) Prognostic significance of chaperonin-containing tailless complex polypeptide 6A (CCT6A) in Ewing sarcoma. Asian Pac J Cancer Prev 26(3):1079\u20131087. https:\/\/doi.org\/10.31557\/APJCP.2025.26.3.1079","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"12766_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23793","volume":"35","author":"J Ma","year":"2021","unstructured":"Ma J, Yang L, Feng H, Zheng L, Meng H, Li X (2021) CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients. J Clin Lab Anal 35(8):e23793. https:\/\/doi.org\/10.1002\/jcla.23793","journal-title":"J Clin Lab Anal"},{"key":"12766_CR73","doi-asserted-by":"publisher","DOI":"10.1159\/000539042","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang H (2025) CCT6A Regulates Cervical Cancer Cell Glycolysis and Proliferation under Hypoxic Conditions via the Telomerase Cajal Body Protein 1\/Telomerase Reverse Tranase. Gynecol Obstetric Investigation. https:\/\/doi.org\/10.1159\/000539042","journal-title":"Gynecol Obstetric Investigation"},{"issue":"8","key":"12766_CR74","first-page":"1110","volume":"26","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Zhang Y, Lin QH (2006) Progesterone-modulated proteins in human endometrial cancer cell line Ishikawa. Nan Fang Yi Ke da Xue Xue Bao = J Southern Medical Uni 26(8):1110\u20131113","journal-title":"Nan Fang Yi Ke da Xue Xue Bao = J Southern Medical Uni"},{"key":"12766_CR75","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-023-03461-z","author":"S Peng","year":"2024","unstructured":"Peng S, Yu J, Wang Y (2024) CCT6A dysregulation in surgical prostate cancer patients: association with disease features, treatment information, and prognosis. Irish J Medical Sci. https:\/\/doi.org\/10.1007\/s11845-023-03461-z","journal-title":"Irish J Medical Sci"},{"issue":"10082","key":"12766_CR76","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi L, Collard HR, Jones MG (2017) Idiopathic pulmonary fibrosis. Lancet 389(10082):1941\u20131952. https:\/\/doi.org\/10.1016\/S0140-6736(17)30866-8","journal-title":"Lancet"},{"key":"12766_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2025.102396","volume":"91","author":"M Li","year":"2025","unstructured":"Li M, Chen B, Zhang X, Zhuo T, Liu X (2025) Advances in novel therapeutics for idiopathic pulmonary fibrosis. Pulm Pharmacol Ther 91:102396. https:\/\/doi.org\/10.1016\/j.pupt.2025.102396","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"12766_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100524","volume":"22","author":"L Wang","year":"2023","unstructured":"Wang L, Zhu M, Li Y, Yan P, Li Z, Chen X, Yang J, Pan X, Zhao H, Wang S, Yuan H, Zhao M, Sun X, Wan R, Li F, Wang X, Yu H, Rosas I, Ding C, Yu G (2023) Serum proteomics identifies biomarkers associated with the pathogenesis of idiopathic pulmonary fibrosis. Mol Cell Proteomics 22(4):100524. https:\/\/doi.org\/10.1016\/j.mcpro.2023.100524","journal-title":"Mol Cell Proteomics"},{"key":"12766_CR79","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjae021","author":"P Yan","year":"2024","unstructured":"Yan P, Yang K, Xu M, Zhu M, Duan Y, Li W, Liu L, Liang C, Li Z, Pan X, Wang L, Yu G (2024) CCT6A alleviates pulmonary fibrosis by inhibiting HIF-1alpha-mediated lactate production. J Molecul Cell Biol. https:\/\/doi.org\/10.1093\/jmcb\/mjae021","journal-title":"J Molecul Cell Biol"},{"key":"12766_CR80","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.700070","author":"H Chen","year":"2016","unstructured":"Chen H, You H, Wang L, Zhang X, Zhang J, He W (2016) Chaperonin-containing T-complex Protein 1 Subunit zeta Serves as an Autoantigen Recognized by Human Vdelta2 gammadelta T Cells in Autoimmune Diseases. J biological chemistry. https:\/\/doi.org\/10.1074\/jbc.M115.700070","journal-title":"J biological chemistry"},{"key":"12766_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23021009","author":"EM Templeton","year":"2022","unstructured":"Templeton EM, Lasse M, Kleffmann T, Ellmers LJ, Palmer SC, Davidson T, Scott NJA, Pickering JW, Charles CJ, Endre ZH, Cameron VA, Richards AM, Rademaker MT, Pilbrow AP (2022) Identifying Candidate Protein Markers of Acute Kidney Injury in Acute Decompensated Heart Failure. International J Molecul Sci. https:\/\/doi.org\/10.3390\/ijms23021009","journal-title":"International J Molecul Sci"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12766-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12766-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12766-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:05:19Z","timestamp":1789736719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12766-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12766"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12766-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"23 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1596"}}